Hepatitis elimination will not be possible unless the communities most disparately impacted have access to the services, tools, and programs that prevent new cases from occurring, link existing cases to treatment, and ensure individuals are informed and ready to participate. Lack of access to sterile syringes is a key driver of new hepatitis cases, but syringe exchange is not the only form of harm reduction and not the only intersection of hepatitis and harm reduction services. In this workshop, presenters will provide their first-hand experience and lessons learned from running harm reduction programs that reduce or prevent viral hepatitis through innovative approaches like safer smoking kits, peer-to-peer navigation, and building syringe access programs in faith-based settings.